Human rotavirus K8 strain represents a new VP4 serotype

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Human rotavirus (HRV) is a leading cause of severe diarrheal disease in infants and young children worldwide.
• The VP4 protein is a major outer capsid protein of HRV, crucial for viral attachment and entry, and a target for serotyping.
• Understanding VP4 diversity is essential for vaccine development and diagnostic strategies.

Purpose of the Study:

• To clone and express the VP4 gene of the human rotavirus K8 strain (G1 serotype) using a baculovirus expression system.
• To characterize the expressed VP4 protein antigenically and immunologically.
• To determine the VP4 serotype of the K8 strain and its relationship to other HRV strains.

Main Methods:

• Cloning of the complete VP4 gene from HRV K8 strain into the baculovirus transfer vector pVL941.
• Generation of a recombinant baculovirus (K8VP4) via cotransfection of Spodoptera frugiperda (Sf9) cells.
• Expression and characterization of VP4 protein in infected Sf9 cells.
• Immunization of guinea pigs with the expressed VP4 protein and subsequent neutralization assays and immunoprecipitation.

Main Results:

• A recombinant baculovirus successfully expressed a protein antigenically similar to authentic K8 VP4.
• Guinea pig antiserum against the expressed VP4 neutralized the K8 HRV strain.
• The antiserum showed reduced neutralization efficiency against other HRV VP4 serotypes (1A, 1B, 2), indicating K8 is a distinct P3 serotype.
• Cross-immunoprecipitation studies revealed limited epitope sharing between K8 VP4 and other serotypes.

Conclusions:

• The human rotavirus K8 strain represents a distinct VP4 serotype (P3).
• The expressed VP4 protein is immunogenic and elicits neutralizing antibodies.
• The K8 VP4 protein possesses unique epitopes, suggesting limited cross-protection from existing HRV vaccines or serological assays targeting other VP4 types.